Literature DB >> 12542835

Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.

Hiroyuki Kumamoto1, Kensuke Yamauchi, Mitsuhide Yoshida, Kiyoshi Ooya.   

Abstract

BACKGROUND: To evaluate the roles of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in tumor progression, expression of MMP-1, -2 and -9 and TIMP-1 and -2 was analyzed in ameloblastomas as well as tooth germs.
METHODS: Frozen tissue sections of seven tooth germs and 22 ameloblastomas were immunohistochemically examined using anti-MMP-1, -2 and -9 and anti-TIMP-1 and -2 antibodies.
RESULTS: MMP-1, -2 and -9 and TIMP-1 and -2 were expressed strongly in mesenchymal components of tooth germs, and stromal cells of ameloblastomas. Immunoreactivity for MMP-9 in stromal cells of ameloblastomas was significantly stronger than in mesenchymal cells of dental follicles and dental papillae. Dental laminae showed weak MMP-2 expression in six tooth germs, MMP-9 expression in two tooth germs and TIMP-1 expression in six tooth germs. Some tumor cells showed weak MMP-2 expression in 19 ameloblastomas, MMP-9 expression in four ameloblastomas and TIMP-1 expression in all cases. TIMP-2 reactivity was prominently found in basement membrane zones of dental laminae in tooth germs, and tumor cell islands or nests in ameloblastomas.
CONCLUSION: Expression of MMPs and TIMPs was considered to be associated with interactions between epithelial cells and mesenchymal components in normal and neoplastic odontogenic tissues; these molecules might play a role in regulation of tumor progression in ameloblastomas as well as regulation of developmental processes in tooth germs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542835     DOI: 10.1034/j.1600-0714.2003.00086.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  17 in total

1.  Immunohistochemistry of Five Molecular Markers for Typing and Management of Ameloblastomas: A Retrospective Analysis of 40 Cases.

Authors:  Thasvir Singh; Arun Chandu; John Clement; Christopher Angel
Journal:  J Maxillofac Oral Surg       Date:  2016-06-02

2.  EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma.

Authors:  Marina Rolo Pinheiro da Rosa; Aline Semblano Carreira Falcão; Hellen Thais Fuzii; Maria Sueli da Silva Kataoka; André L R Ribeiro; Enrique Boccardo; Adriane Sousa de Siqueira; Ruy G Jaeger; João de Jesus Viana Pinheiro; Sérgio de Melo Alves Júnior
Journal:  Tumour Biol       Date:  2014-08-07

3.  Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.

Authors:  Bin Zhang; Jin Zhang; Zhi-Ying Xu; Hong-Liang Xie
Journal:  BMC Cancer       Date:  2009-12-08       Impact factor: 4.430

4.  Presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) in ameloblastomas correlate with rupture of the osseous cortical.

Authors:  Eduardo Rodrigues Fregnani; Lays M Sobral; Fabio Abreu Alves; Fernando Augusto Soares; Luis Paulo Kowalski; Ricardo D Coletta
Journal:  Pathol Oncol Res       Date:  2008-12-19       Impact factor: 3.201

5.  Immunohistochemical Detection of p75 Neurotrophin Receptor (p75-NTR) in Follicular and Plexiform Ameloblastoma.

Authors:  Yoithapprabhunath Thukanayakanpalayam Ragunathan; Nirmal Ramadas Madhavan; Sunil Paramel Mohan; Srichinthu Kenniyan Kumar
Journal:  J Clin Diagn Res       Date:  2016-08-01

6.  Matrix metalloproteinase-9 (mmp-9) expression in different subtypes of ameloblastoma.

Authors:  Rachmitha Anne; Ening Krisnuhoni; Chusnul Chotimah; Benny Sjarief Latief
Journal:  J Maxillofac Oral Surg       Date:  2013-05-29

7.  Rates of tooth movement and bone remodeling activity: Self-ligating versus conventional brackets.

Authors:  Leonard-Euler-Andrade-Gomes do Nascimento; Matheus-Melo Pithon; Antônio-Carlos de O Ruellas; Eduardo-Sant Anna Franzotti; Antônio-Cruz-Gonçalves Filho; Margareth-Maria-Gomes de Souza; Ana-Maria Bolognese
Journal:  J Clin Exp Dent       Date:  2020-04-01

8.  Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma.

Authors:  Lucyana Conceição Farias; Carolina Cavaliéri Gomes; Marcela Carolina Rodrigues; Wagner Henriques de Castro; Júlio César Tanos Lacerda; Efigênia Ferreira E Ferreira; Ricardo Santiago Gomez
Journal:  BMC Clin Pathol       Date:  2012-08-06

9.  Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.

Authors:  Anxun Wang; Bin Zhang; Hongzhang Huang; Leitao Zhang; Donglin Zeng; Qian Tao; Jianguang Wang; Chaobin Pan
Journal:  BMC Cancer       Date:  2008-06-30       Impact factor: 4.430

10.  Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.

Authors:  Simone Magagnin Wajner; Clarissa Capp; Beatriz Assis Brasil; Luise Meurer; Ana Luiza Maia
Journal:  Oncol Lett       Date:  2013-12-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.